|23 December 2015|

Europe’s premier annual showcase for industrial biotechnology and the bioeconomy is coming to Glasgow in 2016.

Scotland’s largest city won the competition in the summer to hold the ninth European Forum for Industrial Biotechnology and the Bioeconomy (EFIB) thanks to the hard work of Team Scotland, which includes the IBioIC, Scottish Enterprise, the Scottish Exhibition and Conference Centre (SECC) and Glasgow City Marketing Bureau and partners such as The Knowledge Transfer Network and Innovate UK.

Landing the prestigious event is a landmark moment for the industry here and highlights the country’s position as a prominent hub for the sector in the UK and Europe.

EFIB will be held at the SECC from 18 to 20 October 2016 and will attract industry executives committed to a shift towards renewable, biologically-based manufacturing. EFIB is organised by EuropaBio, Europe’s largest and most influential biotechnology industry group and Smithers Rapra, global leader in rubber, plastics, polymer and composites information products, and will be supported in Glasgow by Team Scotland.

The UK IB market currently includes over 120 companies which generate an annual turnover of over £4 billion. These companies have grown rapidly – since 2010 their joint turnover has leaped by 53%, with an increase of 21% in the number of jobs available in the sector. All are set to continue growth for the foreseeable future.

The level of IB development and investment is particularly high in Scotland thanks to a strong heritage in engineering, and a wealth of natural resources that are ideal for IB activities. World-class academia combined with strong academic and industry partnerships enabled by IBioIC’s ongoing work, means that there is huge potential for the further development and the use of IB in Scotland.

This event will bring a wealth of potential European business to Scotland and an ongoing opportunity to increase visibility of Scottish business opportunities, European partnerships and economic benefits. It will also provide significant opportunities for collaborative projects between Scottish and European organisations and institutions, allowing Scotland to further rise as a world leader in this sector.

Roger Kilburn, CEO of IBioIC said: “The UK biotechnology sector is growing year on year and Scottish companies are at the forefront of this movement. We are delighted to bring EFIB to Glasgow, providing excellent business opportunities for the Scottish economy and demonstrating how innovative we are as a nation.”